PARSACLISIB for Diffuse large b-cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 24 adverse event reports in the FDA FAERS database where PARSACLISIB was used for Diffuse large b-cell lymphoma.
Most Reported Side Effects for PARSACLISIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 23 | 31.1% | 1 | 8 |
| Disease progression | 15 | 20.3% | 1 | 1 |
| Pyrexia | 14 | 18.9% | 0 | 10 |
| Pneumonia | 11 | 14.9% | 0 | 9 |
| Bronchitis | 9 | 12.2% | 0 | 9 |
| Neutropenic sepsis | 9 | 12.2% | 0 | 9 |
| Neutrophil count decreased | 9 | 12.2% | 0 | 9 |
| Blood lactate dehydrogenase increased | 8 | 10.8% | 0 | 1 |
| Neutropenia | 8 | 10.8% | 1 | 2 |
| Hypokalaemia | 7 | 9.5% | 0 | 7 |
| Enterococcal bacteraemia | 6 | 8.1% | 0 | 0 |
| Intentional product use issue | 6 | 8.1% | 0 | 6 |
| Thrombocytopenia | 6 | 8.1% | 0 | 0 |
| Acute kidney injury | 5 | 6.8% | 1 | 4 |
| Alanine aminotransferase increased | 5 | 6.8% | 1 | 0 |
Other Indications for PARSACLISIB
Mantle cell lymphoma (11)
Follicular lymphoma (7)
B-cell lymphoma (6)
Product used for unknown indication (5)
Other Drugs Used for Diffuse large b-cell lymphoma
RITUXIMAB (22,275)
CYCLOPHOSPHAMIDE (16,598)
DOXORUBICIN (15,213)
VINCRISTINE (14,922)
PREDNISONE (11,266)
LENALIDOMIDE (7,858)
ETOPOSIDE (4,698)
PREDNISOLONE (4,086)
CYTARABINE (3,857)
DEXAMETHASONE (3,696)